These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26124369)

  • 1. Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer.
    Alanee S; Moore A; Nutt M; Holland B; Dynda D; El-Zawahry A; McVary KT
    Anticancer Res; 2015 Jul; 35(7):4145-50. PubMed ID: 26124369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.
    Zaffuto E; Pompe R; Zanaty M; Bondarenko HD; Leyh-Bannurah SR; Moschini M; Dell'Oglio P; Gandaglia G; Fossati N; Stabile A; Zorn KC; Montorsi F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2017 Oct; 15(5):e793-e800. PubMed ID: 28506524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.
    Wang J; Xu W; Mierxiati A; Huang Y; Wei Y; Lin G; Dai B; Freedland SJ; Qin X; Zhu Y; Ye DW
    Prostate; 2019 Sep; 79(13):1563-1571. PubMed ID: 31376193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
    Zhu J; Liang X; Wu D; Chen S; Yang B; Mao W; Shen D
    Medicine (Baltimore); 2021 Apr; 100(15):e25237. PubMed ID: 33847621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
    Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
    Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.
    Marcus DM; Goodman M; Jani AB; Osunkoya AO; Rossi PJ
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):283-8. PubMed ID: 22349984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
    McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
    Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of neuroendocrine prostate cancer.
    Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
    Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
    Tsai HK; Lehrer J; Alshalalfa M; Erho N; Davicioni E; Lotan TL
    BMC Cancer; 2017 Nov; 17(1):759. PubMed ID: 29132337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.
    Lin D; Dong X; Wang K; Wyatt AW; Crea F; Xue H; Wang Y; Wu R; Bell RH; Haegert A; Brahmbhatt S; Hurtado-Coll A; Gout PW; Fazli L; Gleave ME; Collins CC; Wang Y
    Oncotarget; 2015 Jan; 6(3):1806-20. PubMed ID: 25544761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
    Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
    Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
    Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
    Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
    Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives.
    Santoni M; Conti A; Burattini L; Berardi R; Scarpelli M; Cheng L; Lopez-Beltran A; Cascinu S; Montironi R
    Biochim Biophys Acta; 2014 Dec; 1846(2):630-7. PubMed ID: 25450825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine prostate cancer].
    Kretschmer A; Wittekind C; Stief CG; Gratzke C
    Urologe A; 2015 Dec; 54(12):1779-83. PubMed ID: 26582381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
    Shafqat H; Ali S; Salhab M; Olszewski AJ
    Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Denmark 1978-2009--trends in incidence and mortality.
    Outzen M; Brasso K; Martinussen N; Christensen J; Tjønneland A; Friis S; Olsen A
    Acta Oncol; 2013 May; 52(4):831-6. PubMed ID: 22809166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
    Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
    Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.